Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
$5.51
$4.00
$6.92
$200.47M2.16189,500 shs64,100 shs
MYOS
MYOS RENS Technology
$3.35
$0.74
$3.85
$16.70M1.081.68 million shsN/A
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
$0.83
+29.7%
$0.80
$0.50
$6.85
$2.94M1.4460,625 shs7.17 million shs
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.06
+3.9%
$1.78
$0.94
$9.38
$470K12.27 million shs801,395 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
0.00%0.00%0.00%0.00%0.00%
MYOS
MYOS RENS Technology
0.00%0.00%0.00%-54.41%+389.29%
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
+29.69%+27.48%+14.48%+22.04%-78.44%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
+3.92%-9.40%-40.78%-39.77%-80.99%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
MYOS
MYOS RENS Technology
N/AN/AN/AN/AN/AN/AN/AN/A
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
2.454 of 5 stars
3.55.00.00.00.02.50.6
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
N/AN/AN/AN/A
MYOS
MYOS RENS Technology
N/AN/AN/AN/A
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
3.00
Buy$4.00381.99% Upside
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Latest KMPH, MYOS, SXTC, and PHIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/6/2024
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$6.00 ➝ $4.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
$10.72M0.00N/A23.28$3.63 per share0.00
MYOS
MYOS RENS Technology
$1.03M0.00N/AN/A$0.13 per share0.00
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
N/AN/AN/AN/A$2.06 per shareN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.97M0.25N/AN/A$32.12 per share0.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
-$8.56MN/A0.00N/AN/A-328.56%-16.12%-14.17%N/A
MYOS
MYOS RENS Technology
-$4.26MN/AN/AN/AN/A-277.82%-166.68%-104.95%N/A
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
-$10.83M-$5.93N/AN/AN/A-134.66%-105.86%5/9/2024 (Estimated)
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-$5.93MN/A0.00N/AN/AN/AN/A7/29/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
N/AN/AN/AN/AN/A
MYOS
MYOS RENS Technology
N/AN/AN/AN/AN/A
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
N/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
0.14
10.10
10.10
MYOS
MYOS RENS Technology
0.11
3.78
1.94
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
N/A
5.70
5.71
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.02
1.47
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
19.39%
MYOS
MYOS RENS Technology
4.97%
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
57.31%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
5.02%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Zevra Therapeutics, Inc. stock logo
KMPH
Zevra Therapeutics
2234.51 million34.13 millionOptionable
MYOS
MYOS RENS Technology
1512.19 millionN/ANot Optionable
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
94.59 million4.56 millionNot Optionable
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
78460,000439,000Not Optionable

KMPH, MYOS, SXTC, and PHIO Headlines

SourceHeadline
JAGX, BSGM and SXTC among mid-day moversJAGX, BSGM and SXTC among mid-day movers
msn.com - April 16 at 12:56 PM
China SXT Pharmaceuticals Inc.China SXT Pharmaceuticals Inc.
wsj.com - February 23 at 5:50 PM
China SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider TradesChina SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider Trades
benzinga.com - February 23 at 2:49 AM
China SXT Pharmaceuticals, Inc. (SXTC)China SXT Pharmaceuticals, Inc. (SXTC)
finance.yahoo.com - February 17 at 1:28 AM
Thinking about buying stock in Macys, Fisker, Verizon, Terawulf, or China SXT Pharmaceuticals?Thinking about buying stock in Macy's, Fisker, Verizon, Terawulf, or China SXT Pharmaceuticals?
wkrn.com - January 4 at 3:10 PM
Dow Down 100 Points; US Manufacturing PMI Falls In DecemberDow Down 100 Points; US Manufacturing PMI Falls In December
markets.businessinsider.com - January 2 at 12:52 PM
China SXT Pharma Continues To SpikeChina SXT Pharma Continues To Spike
nasdaq.com - December 31 at 12:49 PM
China SXT Pharmaceuticals Inc Ordinary Shares SXTCChina SXT Pharmaceuticals Inc Ordinary Shares SXTC
morningstar.com - December 20 at 12:33 AM
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
finance.yahoo.com - October 26 at 8:13 PM
China SXT Pharmaceuticals, Inc.  Regained Compliance with Nasdaq’s Minimum Bid Price RuleChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
finance.yahoo.com - October 26 at 8:13 PM
Sharp increase in SXTC’s short interest leads to surge in days-to-cover ratioSharp increase in SXTC’s short interest leads to surge in days-to-cover ratio
knoxdaily.com - October 5 at 4:07 PM
China SXT Pharma (NASDAQ: SXTC) to jump 2,500% - a purely technical moveChina SXT Pharma (NASDAQ: SXTC) to jump 2,500% - a purely technical move
dhakatribune.com - October 5 at 4:23 AM
China SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitChina SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
finanznachrichten.de - October 4 at 3:53 PM
China SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5China SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5
markets.businessinsider.com - October 4 at 10:53 AM
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitChina SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
finance.yahoo.com - October 4 at 10:53 AM
Investing in China SXT Pharmaceuticals Inc (SXTC): What You Must KnowInvesting in China SXT Pharmaceuticals Inc (SXTC): What You Must Know
knoxdaily.com - September 27 at 7:28 PM
Checking in on China SXT Pharmaceuticals Inc. (SXTC) after recent insiders movementChecking in on China SXT Pharmaceuticals Inc. (SXTC) after recent insiders movement
knoxdaily.com - September 13 at 7:14 PM
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?
investorplace.com - September 7 at 9:05 AM
China SXT Pharmaceuticals Inc.’s latest rating changes from various analystsChina SXT Pharmaceuticals Inc.’s latest rating changes from various analysts
knoxdaily.com - August 30 at 8:48 PM
SXTC China SXT Pharmaceuticals, Inc.SXTC China SXT Pharmaceuticals, Inc.
seekingalpha.com - August 25 at 8:57 AM
Recent Insider Activity Suggests Potential Gains for China SXT Pharmaceuticals Inc. (SXTC)Recent Insider Activity Suggests Potential Gains for China SXT Pharmaceuticals Inc. (SXTC)
knoxdaily.com - August 23 at 5:08 PM
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?
markets.businessinsider.com - August 21 at 8:53 AM
China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)
finance.yahoo.com - August 2 at 10:21 AM
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleChina SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
finance.yahoo.com - May 10 at 3:51 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Zevra Therapeutics logo

Zevra Therapeutics

NASDAQ:KMPH
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

MYOS RENS Technology

NASDAQ:MYOS
MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.
Phio Pharmaceuticals logo

Phio Pharmaceuticals

NASDAQ:PHIO
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
China SXT Pharmaceuticals logo

China SXT Pharmaceuticals

NASDAQ:SXTC
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.